文传商讯
Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1
2025-09-08 21:48:42
Triangle Life releases Private Purpose: A New Lens on How the Global Wealthy Define and Drive Positi
2025-09-08 21:48:42
CAPR截止日期:Rosen Law Firm敦促蒙受损失的Capricor Therapeutics, Inc. (NASDAQ: CAPR) 股东与律所联系
2025-09-08 21:48:42



